Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia

Blood. 2006 Apr 1;107(7):3012-3. doi: 10.1182/blood-2005-10-4175.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / therapeutic use
  • Arsenic / blood
  • Arsenic / cerebrospinal fluid*
  • Arsenic Trioxide
  • Arsenicals / administration & dosage
  • Arsenicals / pharmacokinetics
  • Arsenicals / therapeutic use*
  • Humans
  • Leukemia, Promyelocytic, Acute / blood
  • Leukemia, Promyelocytic, Acute / cerebrospinal fluid*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Meningeal Neoplasms / blood
  • Meningeal Neoplasms / cerebrospinal fluid
  • Meningeal Neoplasms / drug therapy
  • Meningeal Neoplasms / secondary*
  • Middle Aged
  • Oxides / administration & dosage
  • Oxides / pharmacokinetics
  • Oxides / therapeutic use*
  • Recurrence

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Arsenic
  • Arsenic Trioxide